Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Ceramides and Myo-Inositol are closely matched across evidence, studies, and safety.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
5 of 10 studies with measurable effects showed benefit.
Top outcomes
350mg wheat-derived ceramides or 30-40mg glycosphingolipids daily
Once daily with food
Wheat-derived phytoceramides (Ceramide-PCD)
2-4g daily for PCOS; up to 12-18g for anxiety
Divided doses with meals, Morning and evening
Myo-inositol powder
4-8 weeks
8-12 weeks
4-8 weeks
3-6 months
4-6 weeks
2-3 months
Initial use or high doses
Ceramides and depression: A systematic review
Journal of affective disorders (2017) · Systematic review · n=14
Pharmacotherapy targeting ceramide metabolism may be a novel treatment option for depression.
Effect of oral intake of phytoceramides on skin hydration: A systematic review and meta-analysis of clinical studies
Journal of Cosmetic Dermatology (2021) · Meta analysis · n=542
Oral phytoceramides significantly increased skin hydration measured by corneometry
Oral supplementation with plant-derived ceramides improves skin barrier function and reduces skin dryness: A randomized, double-blind, placebo-controlled trial
Journal of the European Academy of Dermatology and Venereology (2017) · Rct · n=66
Skin hydration was significantly improved after 60 days of phytoceramide supplementation
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
The Cochrane database of systematic reviews (2023) · Meta analysis · n=1319
For the primary neonatal outcomes, only one study measured the risk of a large-for-gestational-age infant and found myo-inositol was associated with both appreciable benefit and harm (RR 1.40, 95% CI 0.65 to 3.02; 1 study, 234 infants; low-certainty evidence).
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=1321
Pooled results were expressed as relative risk (RR) or mean difference (MD) with a 95% confidence interval (95% CI).
Short period-administration of myo-inositol and metformin on hormonal and glycolipid profiles in patients with polycystic ovary syndrome: a systematic review and updated meta-analysis of randomized controlled trials
European review for medical and pharmacological sciences (2022) · Meta analysis · n=612
Compared with metformin, the suitable supplemental dosage of myo-ins may be helpful in lowering levels of TG and avoiding adverse events (AEs).
Based on multiple meta-analyses showing improved menstrual regularity and ovulation in PCOS. Evidence quality varies across studies with some showing minimal differences vs placebo. 4g daily most commonly studied dose.
AI-estimated from published studies. Interpret as directional guidance.
Both Ceramides and Myo-Inositol are closely matched — the best choice depends on your specific health goals.
No known interactions between Ceramides and Myo-Inositol have been documented in our database. However, always consult a healthcare provider before combining supplements.